Lisata Therapeutics Stock Current Valuation

LSTA Stock  USD 2.38  0.02  0.83%   
Valuation analysis of Lisata Therapeutics helps investors to measure Lisata Therapeutics' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. The current year's Enterprise Value is expected to grow to about 36.1 M, whereas Enterprise Value Over EBITDA is forecasted to decline to 0.01. Fundamental drivers impacting Lisata Therapeutics' valuation include:
Price Book
0.5831
Enterprise Value
-16 M
Enterprise Value Ebitda
0.8161
Undervalued
Today
2.38
2.42.385.35.2714.0142.42.382.22.24100%
Please note that Lisata Therapeutics' price fluctuation is unstable at this time. Calculation of the real value of Lisata Therapeutics is based on 3 months time horizon. Increasing Lisata Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Lisata Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Lisata Stock. However, Lisata Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  2.38 Real  5.27 Target  14.0 Hype  2.38 Naive  2.24
The real value of Lisata Stock, also known as its intrinsic value, is the underlying worth of Lisata Therapeutics Company, which is reflected in its stock price. It is based on Lisata Therapeutics' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Lisata Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
5.27
Real Value
11.33
Upside
Estimating the potential upside or downside of Lisata Therapeutics helps investors to forecast how Lisata stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Lisata Therapeutics more accurately as focusing exclusively on Lisata Therapeutics' fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
-0.53-0.53-0.53
Details
Hype
Prediction
LowEstimatedHigh
0.122.388.44
Details
Naive
Forecast
LowNext ValueHigh
0.042.248.30
Details
2 Analysts
Consensus
LowTarget PriceHigh
12.7414.0015.54
Details

Lisata Therapeutics Company Current Valuation Analysis

Lisata Therapeutics' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Lisata Therapeutics Current Valuation

    
  (16.03 M)  
Most of Lisata Therapeutics' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Lisata Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Lisata Current Valuation Driver Correlations

Understanding the fundamental principles of building solid financial models for Lisata Therapeutics is extremely important. It helps to project a fair market value of Lisata Stock properly, considering its historical fundamentals such as Current Valuation. Since Lisata Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Lisata Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Lisata Therapeutics' interrelated accounts and indicators.
0.67-0.030.110.50.120.740.350.270.190.630.630.010.110.040.240.190.26-0.21
0.67-0.55-0.330.12-0.260.040.87-0.35-0.120.20.380.47-0.120.560.70.480.690.3
-0.03-0.550.480.080.370.44-0.680.580.480.270.1-0.390.11-0.4-0.38-0.16-0.37-0.37
0.11-0.330.48-0.080.140.4-0.640.360.750.380.06-0.69-0.48-0.56-0.39-0.17-0.36-0.68
0.50.120.08-0.080.790.68-0.020.53-0.050.660.69-0.080.70.020.01-0.160.02-0.23
0.12-0.260.370.140.790.55-0.320.51-0.040.510.49-0.220.59-0.13-0.15-0.17-0.13-0.35
0.740.040.440.40.680.55-0.280.690.30.730.63-0.420.32-0.38-0.28-0.2-0.25-0.57
0.350.87-0.68-0.64-0.02-0.32-0.28-0.5-0.44-0.20.050.760.030.720.810.530.80.5
0.27-0.350.580.360.530.510.69-0.50.520.30.17-0.290.44-0.42-0.29-0.18-0.27-0.58
0.19-0.120.480.75-0.05-0.040.3-0.440.520.280.04-0.36-0.41-0.3-0.060.11-0.04-0.44
0.630.20.270.380.660.510.73-0.20.30.280.91-0.430.18-0.29-0.2-0.13-0.19-0.42
0.630.380.10.060.690.490.630.050.170.040.91-0.270.27-0.04-0.08-0.12-0.07-0.2
0.010.47-0.39-0.69-0.08-0.22-0.420.76-0.29-0.36-0.43-0.270.310.550.80.70.790.44
0.11-0.120.11-0.480.70.590.320.030.44-0.410.180.270.31-0.08-0.04-0.01-0.04-0.07
0.040.56-0.4-0.560.02-0.13-0.380.72-0.42-0.3-0.29-0.040.55-0.080.780.230.760.62
0.240.7-0.38-0.390.01-0.15-0.280.81-0.29-0.06-0.2-0.080.8-0.040.780.71.00.41
0.190.48-0.16-0.17-0.16-0.17-0.20.53-0.180.11-0.13-0.120.7-0.010.230.70.70.27
0.260.69-0.37-0.360.02-0.13-0.250.8-0.27-0.04-0.19-0.070.79-0.040.761.00.70.37
-0.210.3-0.37-0.68-0.23-0.35-0.570.5-0.58-0.44-0.42-0.20.44-0.070.620.410.270.37
Click cells to compare fundamentals

Lisata Current Valuation Historical Pattern

Today, most investors in Lisata Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Lisata Therapeutics' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Lisata Therapeutics current valuation as a starting point in their analysis.
   Lisata Therapeutics Current Valuation   
       Timeline  
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Lisata Therapeutics has a Current Valuation of (16.03 Million). This is 100.11% lower than that of the Biotechnology sector and 100.35% lower than that of the Health Care industry. The current valuation for all United States stocks is 100.1% higher than that of the company.

Lisata Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Lisata Therapeutics' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Lisata Therapeutics could also be used in its relative valuation, which is a method of valuing Lisata Therapeutics by comparing valuation metrics of similar companies.
Lisata Therapeutics is currently under evaluation in current valuation category among its peers.

Lisata Therapeutics Current Valuation Drivers

We derive many important indicators used in calculating different scores of Lisata Therapeutics from analyzing Lisata Therapeutics' financial statements. These drivers represent accounts that assess Lisata Therapeutics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Lisata Therapeutics' important valuation drivers and their relationship over time.
202020212022202320242025 (projected)
Market Cap25.9M22.1M46.5M13.1M15.1M14.3M
Enterprise Value24.2M12.2M6.2M22.5M25.9M36.1M

Lisata Therapeutics ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Lisata Therapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Lisata Therapeutics' managers, analysts, and investors.
Environmental
Governance
Social

Lisata Fundamentals

Return On Equity-0.48
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-600%-500%-400%-300%-200%-100%
Return On Asset-0.3
Current Valuation(16.03 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-80%-60%-40%-20%
Shares Outstanding8.39 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-311,000,000%2,000,000%3,000,000%4,000,000%
Shares Owned By Insiders19.24 %
Shares Owned By Institutions9.36 %
Number Of Shares Shorted26.7 K
Price To Book0.58 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-120%-100%-80%-60%-40%-20%
EBITDA(25.52 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-311,000%2,000%3,000%4,000%5,000%
Net Income(20.84 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-1,000%0%1,000%2,000%
Cash And Equivalents72.99 M
Cash Per Share18.07 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%-80%-60%-40%-20%
Total Debt305 K
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%200%400%600%
Debt To Equity0.01 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-150%-100%-50%
Current Ratio22.33 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%2,000%2,500%
Book Value Per Share4.05 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-120%-100%-80%-60%-40%-20%
Cash Flow From Operations(20.03 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-20,000%-15,000%-10,000%-5,000%
Short Ratio0.47 X
Earnings Per Share(2.51) X
Price To Earnings To Growth(0.02) X
Target Price17.0
Number Of Employees25
Beta1.15
Market Capitalization19.98 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-60%-40%-20%0%
Total Asset54.69 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-311,000%2,000%3,000%4,000%
Retained Earnings(528.08 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-311,000%2,000%3,000%4,000%
Working Capital47.33 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Net Asset54.69 M

About Lisata Therapeutics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Lisata Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lisata Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lisata Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Lisata Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Lisata Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Lisata Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Lisata Therapeutics Stock:
Check out Lisata Therapeutics Piotroski F Score and Lisata Therapeutics Altman Z Score analysis.
For information on how to trade Lisata Stock refer to our How to Trade Lisata Stock guide.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lisata Therapeutics. If investors know Lisata will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lisata Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.51)
Return On Assets
(0.30)
Return On Equity
(0.48)
The market value of Lisata Therapeutics is measured differently than its book value, which is the value of Lisata that is recorded on the company's balance sheet. Investors also form their own opinion of Lisata Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Lisata Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lisata Therapeutics' market value can be influenced by many factors that don't directly affect Lisata Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lisata Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lisata Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lisata Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.